a drug with loss of control over drug intake. The term drug that is administered over time, the larger the withsubstance dependence is used to describe a syndrome drawal response. basically equivalent to addiction and the diagnostic criIf a deficit reward state defines addiction, it could teria used describe symptoms that lead to loss of control be produced by several mechanisms. First, genetic or in drug intake. Substance use, substance abuse, and environmental factors could produce some neurobiosubstance dependence are separate, definable entities logical deficit that requires reversal, perhaps by drug in most formulations. An important challenge for neuroinitiation. Alternatively, chronic drug taking itself could biological research is to understand how the transition produce a form of deficit state that required self-medicaoccurs between controlled drug use and the loss of tion to reverse. This type of deficit state could be hypothcontrol that defines addiction or substance dependence esized to exist at the molecular, cellular, and system and what molecular, cellular, and system processes level, and the minireviews in this issue discuss numerous contribute to the development of drug dependence. A neuropharmacological mechanisms for such perturbaneuroadaptive view of drug dependence was originally tions. based on the phenomenon of tolerance and withdrawal, However, drug dependence not only involves acquisiadaptive processes that have been hypothesized to be tion of drug taking and maintenance of drug taking, the body's attempt to counter the acute effects of the but also functions as a chronic relapsing disorder with drug. Such adaptations have been explored at all levels reinstatement of drug taking after detoxification and abof drug dependence research from the behavioral to the stinence. Both the positive and negative affective states molecular (reviewed by Koob and Bloom, 1988) . More can become associated with stimuli in the drug-taking recently, another adaptive process, the phenomenon environment or even internal cues through classical conof sensitization, has been conceptualized as a critical ditioning processes (Wikler, 1973) . Reexposure to these neuroadaptive process (Robinson and Berridge, 1993) .
conditioned stimuli can provide the motivation for continued drug use and relapse after abstention. There is Motivational View of Drug Dependence evidence in humans that the positive reinforcing effects There are four major sources of reinforcement in drug of drugs such as heroin and cocaine, as measured by dependence: positive reinforcement and negative reinsubjective reports of euphoria or "high," can become forcement, conditioned positive reinforcement, and conditioned to previously neutral stimuli. Patients being conditioned negative reinforcement (Wikler, 1973) . treated for heroin addiction and allowed to self-adminisClearly, positive reinforcing effects are critical for estabter either saline or heroin reported that both saline and lishing self-administration behavior, which leads to the heroin injections were pleasurable, particularly in the hypothesis that positive reinforcement is the key to drug patient's usual injection environment. Alternatively, padependence (Wise, 1988) . In contrast, neuroadaptation tients, even detoxified subjects, can report negative aftheories, such as opponent-process theory, postulate fective symptoms like those associated with drug abstithat the processes of affective habituation (hedonic tolnence when returning to environments similar to those erance) and affective withdrawal may be the driving associated with drug dependence (O'Brien, 1976) . The force of addiction (Solomon, 1977) . Clearly, this conneurobiological bases for the syndrome of protracted struct plays an important role in the maintenance of drug abstinence may involve subtle molecular and cellular use after the development of dependence. Thus, while changes that are the challenge of future research on the initial drug use may be motivated by the positive afneurobiology of addiction. Key elements of some of the fective state produced by the drug, continued use leads neuroadaptive processes that constitute protracted abto neuroadaptation to the presence of drug and to anstinence can be found in the minireviews of this issue. other source of reinforcement, the negative reinforcement associated with relieving negative affective conseNeuroadaptive Theories for Tolerance quences of drug termination. Indeed, the defining and Withdrawal feature of drug dependence has been argued to be the Tolerance has been hypothesized to develop via two establishment of a negative affective state (Russell, possible mechanisms. Habituation occurs when the pri-1976).
mary response to the drug diminishes with repeated While a negative affective state is difficult to measure presentation. Alternatively, the initial acute effect of the in animals, there is evidence of a compromised brain drug may be opposed or counteracted by homeostatic reward system during drug withdrawal in chronically changes in systems that mediate the primary drug efexposed animals. Intracranial self-stimulation (ICSS) befects, i.e., a homeostatic adaptive process. These two havior has proven to be particularly sensitive to changes models are not necessarily mutually exclusive (Littleton in the brain reward systems during the course of drug dependence. Acute administration of drugs that are and Little, 1989).
In the opponent-process theory, both tolerance and Cellular and Molecular Adaptations Associated with Brain Motivational Systems dependence are inextricably linked (Solomon, 1977) . According to this theory, affective states, pleasant or averOpiates Chronic morphine treatment has long been associated sive, are automatically opposed by centrally mediated mechanisms that reduce the intensity of these affective with increases in adenylate cyclase activity, an action opposite to that of acute administration (Nestler, 1996 states. Thus, positive reinforcers such as drugs engage positive hedonic processes that are opposed by nega-[this issue of Neuron]). These effects have not only been observed in the locus coeruleus, a brain structure implitive hedonic processes. The positive hedonic processes are hypothesized to be simple and stable and to follow cated in the physical signs of opiate withdrawal, but also in the region of the nucleus accumbens, a structure administration of the drug closely in time. In contrast, the negative hedonic processes are of longer latency, implicated in the motivational effects of opiate withdrawal. In addition, chronic opiate exposure also deslow to build up strength, and slow to decay. Within this framework, the intense pleasure of a drug "rush" or creases levels of neurofilament protein in the ventral tegmental area, which contains the cell bodies of origin "high" is presumed to reflect a positive hedonic process, and the negative mood state associated with the drug of the dopamine (DA) projection to the nucleus accumbens; administration of neurotrophic factors can reverse wearing off or abstinence following a drug binge is presumed to reflect the opponent negative hedonic these effects. Injection of brain-derived neurotrophic factor into the brain prevented and reversed the strucprocess.
tural changes observed in the ventral tegmental area DA neurons as well as the changes in cyclic AMP (cAMP) Sensitization activity in the nucleus accumbens (Nestler, 1996) . This Sensitization has been defined as the long-lasting increopens the possibility that the long-term neuroadaptment in response occurring upon repeated presentation ations associated with opiate dependence that have of a stimulus that reliably elicits a response at its initial motivational consequences may involve changes in presentation. With drugs, sensitization is more likely to mesolimbic DA function that can be regulated by neurooccur with intermittent exposure to a drug, in contrast trophic factors. with tolerance, which is more likely to occur with continCocaine and Amphetamine uous exposure. In a recent conceptualization of the role Two major neurobiological actions of cocaine and amof sensitization in drug dependence, drug craving was phetamine may represent neuroadaptations important hypothesized to be progressively increased by repeated for motivational effects of these drugs. Activation of D1 exposure to drugs of abuse (Robinson and Berridge, receptors stimulates a cascade of events that ultimately 1993); the transition to pathologically strong craving lead to cAMP response element-binding protein (CREB) would then define compulsive use.
phosphorylation and subsequent alterations in gene expression (Hyman, 1996 [this issue of Neuron]). These within-system adaptations not only could change the Within-System and function of the DA system itself but may also trigger a Between-System Neuroadaptations second major neurobiological action, the increase in In an attempt to bring homeostatic models to the cellular expression of protachykinin and prodynorphin mRNA. and molecular levels of analysis, adaptations can be The subsequent activation of dynorphin systems could distinguished between those occurring within a drugcontribute to the dysphoric syndrome associated with sensitive reinforcement system and those occurring becocaine dependence and also provide feedback to detween interacting systems (Koob and Bloom, 1988) . Simcrease DA release. Enhanced dynorphin actions could ilar neurobiological distinctions could also be made for then be considered a between-system adaptation. The the neuroadaptations associated with sensitization. In a significance of the D1 receptor-cAMP-CREB pathway within-system adaptation, repeated drug administration in adaptations to drugs of abuse is supported by the would elicit an opposing reaction within the same sysrecent evidence of effective anti-cocaine actions from tem in which the drug elicits its primary reinforcing ac-DA D1 antagonists and effective anti-cocaine priming tions. In a between-system adaptation, repeated drug effects of D1 agonists (Self et al., 1996) . administration would recruit a different neurochemical Nicotine system, one not involved in the acute reinforcing effects
The initial molecular site of action for nicotine is likely of the drug but one that, when activated or engaged, to be the nicotinic acetylcholine receptors, specifically would act in opposition to the primary reinforcing effects those localized in the brain mesolimbic DA system. The of the drug.
capability of these receptors to exist in many different Many examples of within-system and between-sysfunctional states has led to a combined within-system/ tem adaptations can be found in the four minireviews between-system adaptation hypothesis to explain tolerto follow. Some of these neuroadaptations are specific ance and dependence (Dani and Heinemann, 1996 [this to each drug class, while others may be common to all issue of Neuron]). Acute nicotine briefly stimulates redrugs of abuse. Even more intriguing is the possibility ceptors that are normally in a closed resting state to an that the added system dimension of neurobiological ciropen state for conducting cations, but then they return cuitry may represent not only a common substrate for to a desensitized state in which they are unresponsive the reinforcing actions of drugs but a common substrate to the agonist. In addition, long-term nicotine exposure for the neuroadaptations known as substance depencauses an increase in the actual number of nicotinic acetylcholine receptors. Thus, the following scenario dence or addiction.
has been hypothesized by Dani and Heinemann. Nicoobservation that opioid antagonist administration can tine stimulates the mesolimbic DA system, among other help prevent relapse in detoxified alcoholics (Koob, systems, via activation of nicotinic acetylcholine recep-1996) . Serotonin has been implicated in the acute reintors to produce the reinforcing effects of nicotine. The forcing effects of ethanol by the observation that serotoinactivation of the receptors by desensitization leads to nin reuptake inhibitors decrease ethanol intake in aniacute tolerance, which is compensated by an increase mals and humans (Koob, 1996) . All of these changes in receptors. During abstinence, the smoker's nicotine would be considered within-system changes where the levels fall, and the excess nicotinic acetylcholine recepneurotransmitter system responsible for part of the tors begin to recover to a responsive state. However, acute reinforcing actions of ethanol is altered by chronic this heightened responsitivity to ordinary synaptic input exposure to ethanol. in the acetylcholinergic pathways would not be reOne example of a potential between-system neuroastricted to the receptors on the DA system but may daptation with chronic ethanol is the activation of the engage nicotinic receptors on other, nonrewarding aceneuropeptide corticotropin-releasing factor (CRF), a tylcholinergic pathways that could contribute to the negpeptide implicated in behavioral responses to stressors. ative affective state associated with nicotine withdrawal.
CRF antagonists injected into the amygdala reverse the Smokers are, in effect, medicating themselves with nicoanxiogenic-like effects of ethanol withdrawal, and ethatine to regulate the number of functional nicotinic acetylnol withdrawal is characterized by increased release of choline receptors according to this hypothesis.
CRF into the amygdala (Koob et al., 1994a; Pich et al., Alcohol 1995) . A major advance in recent years has been the discovery of significant selectivity in the initial site of action of ethanol, particularly for low doses. Rather than acting Common Neuropharmacological Elements through relatively unselective perturbations of memin Addiction brane lipids, ethanol appears to act selectively on pro-
The changes in the brain associated with the developteins involved in signal transmission and transduction ment of drug dependence outlined above have several (Tabakoff and Hoffman, 1996 [ 
this issue of Neuron]).
common elements that may define a basic drug adFive neurotransmitter systems have been implicated in diction circuitry. This circuitry can be defined at three the acute reinforcing actions of ethanol: ␥-aminobutyric levels of inquiry: molecular, neurochemical, or neuroanacid (GABA), glutamate, DA, serotonin, and opioid pepatomical. tides (Koob et al., 1994b) . Recent work has begun to Within-System identify elements of neuroadaptation in these neuro-A system common to the acute and chronic actions of transmitter systems that result from chronic administraall drugs of abuse is the mesolimbic DA system. Activation of ethanol. Pharmacological data suggest a role for tion of this system is critical for the reinforcing actions of GABA in ethanol dependence in that GABA agonists stimulants, possibly including nicotine. The mesolimbic attenuate ethanol withdrawal and GABA antagonists ex-DA system also participates in opiate and alcohol reinacerbate ethanol withdrawal. At a molecular level, there forcement, although its integrity is not critical to support are data showing that the potentiation by ethanol of GABA-stimulated chloride flux is greatly reduced by self-administration of those drugs. Drug withdrawal is chronic exposure to ethanol, and there are changes accompanied by a decrease in DA function, and elein the expression of particular subunits of the GABA A ments of protracted abstinence may involve long-term receptor with chronic ethanol exposure. changes in the DA system. Neuroadaptation within this In contrast with the potentiation of GABA signaling, system clearly can develop by various means from the there is significant evidence that acute ethanol at quite desensitization of nicotinic receptors (Dani and Heinelow doses decreases glutamate (NMDA) receptor funcmann, 1996) to the induction of signal transduction eletion, possibly through an action on the glycine site of ments pre-and postsynaptically to changes in response the receptor. Chronic treatment with ethanol appears to to growth factors (Nestler, 1996) . Evidence is strong for increase the number of binding sites for NMDA receptor changes in opiate receptor signal transduction associligands that again may reflect changes in the absolute ated with chronic opiates (Nestler, 1996) , but indirect or relative quantity of NMDA receptor subunit proteins.
evidence also exists for changes with cocaine and even These effects on GABA A and NMDA receptor function chronic ethanol (Nestler, 1992) . may be examples of within-system adaptations, but the Between-System link to actual motivational effects of ethanol dependence Evidence for between-systems adaptations following remains to be determined. chronic drugs of abuse can be found in studies exploring Two brain systems definitely linked to the motivational the role of several neuropeptides, notably dynorphin, effects of ethanol are the DA system and the opioid CRF, and neuropeptide FF (NPFF). Dynorphin peptides peptide systems. Ethanol does appear to activate the appear to regulate the DA system via an action of mesolimbic DA system, possibly through an interaction opioid receptors on DA nerve terminals; and agonists with NMDA receptors, but perhaps more intriguing is produce aversive effects in rodents and humans (Hythe observation that DA function is decreased during man, 1996). Thus, the induction of prodynorphin gene ethanol withdrawal, and this decrease is reversed by by chronic administration of cocaine or amphetamine ethanol administration (Koob, 1996) . A role for opioid could be an example of a neuroadaptation that is repeptides in ethanol dependence derives from the precruited by the chronic drug exposure but has opposing clinical observation of a decrease in ethanol self-administration with opioid antagonists and from the clinical effects on brain reinforcement systems.
Immunoreactivity for NPFF and its receptors has been to stimuli that predict drug effects or both. One could reported in the CNS of the rat. Anti-opiate activities of speculate that the combination would be particularly NPFF have been hypothesized based on the effects of powerful as a motivator for reinstatement of drug use. intracerebroventricular (ICV) injection of NPFF-related Animal models of drug craving and relapse are being peptides (Malin et al., 1990) . NPFF attenuates morphinedeveloped and refined and usually reflect secondary and stress-induced analgesia, and an NPFF antagosources of reinforcement. The neural substrates for connist can increase both morphine-and stress-induced ditioned positive reinforcement may involve elements analgesia and reverse morphine tolerance. ICV adminisof afferent input of the extended amygdala such as the tration of an NPFF antagonist also attenuates a naloxafferents from the basolateral amygdala and the mesoone-precipitated withdrawal syndrome in morphine-delimbic DA system. The neural substrates for conditioned pendent rats. It remains to be determined whether these negative reinforcement are largely unknown. The chalanti-opiate peptides have motivational significance and lenge for future studies in the neurobiology of drug contribute to the negative affective state produced durdependence will be to elucidate the neuroadaptive ing drug abstinence.
changes, such as changes in signal transduction func-CRF is another neuropeptide that may be involved tion and gene expression, produced by chronic drug use in the motivational aspects of drug dependence. Rats in animal models of protracted abstinence and relapse. treated repeatedly with cocaine and ethanol show signifPresumably, the same molecular and cellular changes icant anxiogenic-like responses following cessation of in the neurochemical systems and neurocircuitry rechronic drug administration that are reversed with ICV sponsible for the positive and negative reinforcement administration of a CRF antagonist (Koob et al., 1994a) . associated with chronic drug use will hold the key. However, a CRF antagonist was also active in reversing the aversive effects of opiate withdrawal (Heinrichs et , 1995) . Thus, CRF activation may be a common eleCaine, S.B., Heinrichs, S.C., Williams, C.E., Coffin, V.L., and Koob, ment associated with the development of drug depen-
